(Q50179282)

26 February 2018

title

Impact of Medicaid preferred drug lists on therapeutic adherence. (English)

1 reference

26 February 2018

author name string

David B Ridley

series ordinal

1

1 reference

26 February 2018

Kirsten J Axelsen

series ordinal

2

1 reference

26 February 2018

publication date

1 January 2006

1 reference

26 February 2018

published in

PharmacoEconomics

1 reference

26 February 2018

volume

24 Suppl 3

1 reference

26 February 2018

page(s)

65-78

1 reference

26 February 2018

https://scigraph.springernature.com/pub.10.2165/00019053-200624003-00006

exact match

0 references

cites work

The effect of incentive-based formularies on prescription-drug utilization and spending

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Employer drug benefit plans and spending on prescription drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Adverse events associated with prescription drug cost-sharing among poor and elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

The assessment of refill compliance using pharmacy records: methods, validity, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

A first look at the new Medicare prescription drug plans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200624003-00006

Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?

21 January 2018

1 reference

12 December 2020

Effect of tiered prescription copayments on the use of preferred brand medications

1 reference

12 December 2020

The effects of prescription drug copayments on statin adherence

1 reference

12 December 2020

Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes

1 reference

12 December 2020

Health insurance and the demand for medical care: evidence from a randomized experiment

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

Cost effects of restricting cost-effective therapy

1 reference

12 December 2020

How effectively do managed care organizations influence prescribing and dispensing decisions?

1 reference

12 December 2020

Medicaid prescription drug access restrictions: exploring the effect on patient persistence with hypertension medications.

1 reference

12 December 2020

Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population

1 reference

12 December 2020

The incidence of mandated maternity benefits

1 reference

12 December 2020

10.2165/00019053-200624003-00006

Identifiers

DOI

1 reference

26 February 2018

Dimensions Publication ID

0 references

1 reference

26 February 2018